Could cause temporary or reversible harm; serious harm is unlikely.
Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.
| Brand name | OXYCODONE AND ACETAMINOPHEN |
| Generic name | OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN |
| Active ingredient(s) | ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE |
| Distributed by / for | SpecGx, LLC |
| NDC | 0406-0523-01 |
| Full product label | Oxycodone and Acetaminophen CII Tablets USP, 10mg/325 mg, 100 tablets, Rx only, SpecGx LLC, Webster Groves, MO 63119, NDC 0406-0523-01. |
| Recalling firm | SpecGx, LLC |
| Distribution | Nationwide |
| Quantity | 287,988 Bottles. |
| Recall initiated | 2025-12-16 |
| Report date | 2026-01-14 |
| Recall completed | — |
| Recall number | D-0254-2026 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Webster Groves MO United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗